Spodim CV

Spodim CV combines Cefpodoxime Proxetil with Potassium Clavulanate to address a wide range of bacterial infections, especially those caused by beta-lactamase producing organisms.

Type:

Antibiotic

Classification:

Cephalosporin

#ANTIBIOTIC #CEPHALOSPORIN #BETA-LACTAMASE #INFECTION

Spodim CV Product Image

Product Overview

Spodim CV offers broad-spectrum antibacterial coverage with enhanced activity against resistant strains by combining a cephalosporin with a beta-lactamase inhibitor.

Composition

  • Cefpodoxime
  • Potassium Clavulanate

Formulation

Tablet

Key Benefits

  • Effective against beta-lactamase producing bacteria
  • Wide range of indications including respiratory and urinary infections
  • Well-tolerated oral formulation

Indications

  • Respiratory tract infections
  • Urinary tract infections
  • Skin and soft tissue infections

Marketed By

Vee Medi Biotech